Hironic Announces 233 Won Cash Dividend per Share

Hironic has decided to pay a cash dividend of 233 won per common share.

According to Hironic on July 20, the total dividend payment amounts to approximately 4 billion won, and the eligible shares are 17,199,046 shares, which is the total number of shares issued after the cancellation of treasury stocks.

After the resumption of trading, the company cancelled all its treasury stocks by means of earnings-based retirement. Following the enhancement of per-share value through a reduction in the number of outstanding shares, this marks the first quarterly cash dividend, thereby expanding its shareholder return policy.

Hironic is also strengthening its new product portfolio. This month alone, the composite medical device ‘Synerjet Pro’ and the microwave medical device ‘Miglow’ obtained item approval from the Ministry of Food and Drug Safety.

The company is also expanding approvals and distribution networks in overseas markets. The ‘New Doublo Series’ has acquired certification from the Federal Commission for Protection Against Sanitary Risk (COFEPRIS) in Mexico and the National Institute for Food and Drug Surveillance (INVIMA) in Colombia, and along with existing certification from the Brazilian Health Regulatory Agency (ANVISA), has established a sales network across three Latin American countries. ‘Synerjet’ has received approval from the Taiwan Food and Drug Administration (TFDA) and has begun shipments.

Hironic continues to expand its international reach, having signed an exclusive distribution agreement for ‘Miglow’ with Singapore's GlobalSCP and for ‘Silkro’ with a medical aesthetics specialist company in the United Arab Emirates (UAE). ‘Synerjet’ is also currently undergoing the United States Food and Drug Administration (FDA) 510(k) certification process.

A Hironic representative stated, “The company’s first-ever quarterly dividend is a first step in repaying shareholders’ trust after the resumption of trading. We will continue to implement predictable and sustainable shareholder return policies, and foster a virtuous cycle in which company value and shareholder value grow together through new product approvals and global market expansion.”

This content was produced with the assistance of AI translation services.